• Product NameVerteporfin
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityVerteporfin(CL 318952; Visudyne), a benzoporphyrin derivative monoacid ring A, is a photosensitising drug for photodynamic therapy (PDT) activated by low-intensity, nonheat-generating light of 689nm wavelength.
• Target NameVDA inhibitor
• CAS No. 129497-78-5
• Calculated MW 718.79
• Formulation C41H42N4O8
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular System
  SMILES:O=C(O)CCC1=C(C)C(/C=C2C(C=C)=C(C)/C(N/2)=C/3)=N/C1=C\C(N4)=C(CCC(OC)=O)C(C)=C4/C=C5[C@]6(C)[C@H](C(OC)=O)C(C(OC)=O)=CC=C6C3=N/5
  Pathways:Angiogenesis
  Receptor:VDA
  Boling pt:
  Melting pt:
  Solubility:DMSO: 100 mg/mL (139.12 mM)
  Appearance:BlackPowder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Schmidt-Erfurth U, et al. Surv Ophthalmol, 2000, 45(3), 195-214.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting